¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pulmonary epithelial cell"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary stenosis
    Æóµ¿¸ÆÆÇÇùÂø(Áõ)
  • pulmonary strongyloidiasis
    ÆóºÐ¼±ÃæÁõ, ÇãÆÄºÐ¼±ÃæÁõ
  • pulmonary surfactant
    ÆóÇ¥¸éȰ¼ºÁ¦, ÇãÆÄÇ¥¸éȰ¼ºÁ¦
  • pulmonary trunk
    Æóµ¿¸Æ, ÇãÆÄµ¿¸Æ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • pulmonary valve
    Æóµ¿¸ÆÆÇ, ÇãÆÄµ¿¸ÆÆÇ
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×
  • pulmonary ventilation
    Æóȯ±â
  • pulmonary ventilatory capacity
    Æóȯ±â¿ë·®
  • right pulmonary artery
    ¿À¸¥ÇãÆÄµ¿¸Æ, ¿ìÆóµ¿¸Æ
  • acantholytic cell
    °¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
  • angioimmunoblastic T-cell lymphoma
    Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
  • annular elastotic giant cell granuloma
    °í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • reticuloendothelial cell
    ±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
  • rod cell
    ¸·´ë¼¼Æ÷
  • round cell
    ¿øÇü¼¼Æ÷
  • satellite cell
    À§¼º¼¼Æ÷
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann's cell
    ½Å°æÁý¼¼Æ÷
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • spindle cell
    ¹æÃß¼¼Æ÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • squamous cell in situ carcinoma
    ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stellate cell
    º°¼¼Æ÷
  • stem cell
    Áٱ⼼Æ÷
  • supporting cell
    ¹öÆÀ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary vasculature
    ÇãÆÄ¸Æ°ü, Æó¸Æ°ü
  • pulmonary alveolar proteinosis
    Æó´Ü¹éÁõ, ÇãÆÄ²Ê¸®´Ü¹éÁõ
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð
  • pulmonary capillary wedge pressure
    ÇãÆÄ¸ð¼¼Ç÷°ü½û±â¾Ð, Æó¸ð¼¼Ç÷°ü½û±â¾Ð
  • pulmonary flow resistance
    Æó±â·ùÀúÇ×
  • pulmonary function test
    Æó±â´É°Ë»ç
  • pulmonary meniscus sign
    ÇãÆÄÃʽ´Þ¡ÈÄ, ÆóÃʽ´Þ¡ÈÄ
  • pulmonary perfusion scan
    ÇãÆÄ°ü·ù½ºÄµ, Æó°ü·ù½ºÄµ
  • pulmonary vascular resistance
    ÇãÆÄÇ÷°üÀúÇ×, ÆóÇ÷°üÀúÇ×
  • total pulmonary resistance
    (¢¡pulmonary vascular) ÇãÆÄÇ÷°üÀúÇ×, ÆóÇ÷°üÀúÇ×
  • acantholytic cell
    °¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acidophilic cell
    È£»ê¼º¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • acinic cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary arteriovenous fistula
    Æóµ¿Á¤¸Æ·ç(øËÔÑð¡Øæ×ª).
  • pulmonary arteriovenous fistula
    Æóµ¿Á¤¸Æ·ç(øËÔÑð¡Øæ×ª)
  • pulmonary artery
    Æóµ¿¸Æ(øËÔÑØæ).
  • pulmonary artery
    ÇãÆÄµ¿¸Æ
  • pulmonary artery
    Æóµ¿¸Æ
  • pulmonary artery
    Æóµ¿¸Æ(øËÔÑØæ).
  • pulmonary artery catheter
    Æóµ¿¸ÆµµÀÚ
  • pulmonary artery pressure
    Æóµ¿¸Æ¾Ð.
  • pulmonary artery ring
    Æóµ¿¸Æ°í¸®, Æóµ¿¸Æ·û(øËÔÑØæëÌ).
  • pulmonary artery wedge pressure
    Æóµ¿¸Æ½û±â¾Ð.
  • pulmonary ascariasis
    ȸÃþÁõ(¡­ñø).
  • pulmonary aspergillosis
    Æó¾Æ½ºÆä¸£±æ·ç½ºÁõ(øË¡­ñø).
  • pulmonary aspergillosis
    Æó¾Æ½ºÆä¸£Áú·ç½º Áõ(øË¡­ñø).
  • pulmonary atelectasis
    ¹«±âÆó(ÙíѨøË).
  • pulmonary atelectasis
    ¹«±âÆó(ÙíѨøË)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • outer epithelial root sheath
  • paradental epithelial cyst
    Ä¡ÁÖ¼º »óÇdz¶(öÍñ²àõß¾ù«Ò¥).
  • punctate epithelial erosion
    Á¡»ó°¢¸·»óÇÇÁø¹«¸§(¹Ì¶õ)
  • retinal pigment epithelial detachment
    ¸Á¸·»ö¼Ò»óÇǹڸ®
  • sclerosing epithelial hamartoma
    °æÈ­ Ç¥Çǰú¿ÀÁ¾
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • beta cell insulin cell
    º£Å¸¼¼Æ÷ Àν´¸°¼¼Æ÷
  • bronchiolar cell clara cell
    ¼¼±â°üÁö¼¼Æ÷
  • cell to cell cooperation
    ¼¼Æ÷°£ÇùÁ¶ÀÛ¿ë(á¬øàÊàúððàíÂéÄ).
  • chief cell type i glomus cell
    °ú¸³¼¼Æ÷
  • clear cell basal cell carcinoma
    Åõ¸í¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
  • clear cell epinephrine cell
    ¹àÀº¼¼Æ÷ ¿¡Çdz×ÇÁ¸°¼¼Æ÷
  • cytotoxic T-cell ; killer T-cell
    (¼¼Æ÷)»ì(ÇØ) T¼¼Æ÷.
  • dark cell norepinephrine cell
    ¾îµÎ¿î¼¼Æ÷ ³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷
  • interstitial cell dark cell
    »çÀÌÁú¼¼Æ÷
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Interstitial cell [Dark cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Interstitial cell [Leydig`s cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Bronchiolar cell [Clara cell]
    ¼¼±â°üÁö¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐºñ¼¼Æ÷
  • Parafollicular cell [Calcitonin cell]
    ¼ÒÆ÷°ç¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÆ÷¹æ¼¼Æ÷
  • Neurolemmal cell [Schwann`s cell]
    ½Å°æÁý¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æÃʼ¼Æ÷
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
  • Dark cell [Norepinephrine cell]
    ¾îµÎ¿î¼¼Æ÷ [³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾Ï¼¼Æ÷(³ë¸£¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Supporting cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷(Á¦2Çü»ç±¸¼¼Æ÷)
  • Striated muscle cell
    °¡·Î¹«´Ì±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] Ⱦ¹®±Ù¼¼Æ÷
  • Cortical endocrine cell
    °ÑÁú³»ºÐºñ¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÇÁú³»ºÐºñ¼¼Æ÷
  • Nodal cell
    °áÀý¼¼Æ÷
    [¿¾ ¿ë¾î] °áÀý¼¼Æ÷
  • Granule cell
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] °ú¸³¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • killer cell
    »ì¼¼Æ÷(ß¯á¬øà)
  • memory cell
    ±â¾ï¼¼Æ÷(ÑÀåãá¬øà)
  • natural killer cell
    ÀÚ¿¬ »ì¼¼Æ÷(í»æÔß¯á¬øà)
  • NK cell
    NK ¼¼Æ÷(á¬øà)
  • nonpermissive cell
    ºñÇã¿ë ¼¼Æ÷(ÞªúÉé»á¬øà)
  • null cell
    ¹«Ç¥Áö¼¼Æ÷(Ùíøúò½á¬øà)
  • permanent cell strain
    ¿µ±¸¼¼Æ÷ÁÖ(çµÎùá¬øàñ»)
  • permissive cell
    Çã¿ë ¼¼Æ÷(úÉé»á¬øà)
  • photoelectric cell
    ±¤ÀüÁö(ÎÃï³ò®)
  • photovoltaic cell
    ±¤ÀüÁö (ÎÃï³ò®)
  • plaque forming cell
    ÇöóÅ© Çü¼º ¼¼Æ÷(û¡à÷á¬øà)
  • plasma cell
    ÇüÁú¼¼Æ÷(û¡òõá¬øà)
  • primed cell
    °¨ÀÛ¼¼Æ÷(ÊïíÂá¬øà)
  • productive cell
    »ý»ê ¼¼Æ÷(ßæß§á¬øà)
  • red cell agglutination
    ÀûÇ÷±¸ ÀÀÁý(îåúìϹëêó¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • germ cell
    »ý½Ä¼¼Æ÷, ¹è¼¼Æ÷
  • giant cell
    °Å¼¼Æ÷
  • giant cell tumor
    °Å¼¼Æ÷Á¾¾ç
  • goblet cell
    ¼úÀܼ¼Æ÷, ¹è³¶¼¼Æ÷
  • granular cell myoblastoma
    °ú¸³¼¼Æ÷±Ù¸ð¼¼Æ÷Á¾
  • granulosa cell
    °ú¸³¸·¼¼Æ÷
  • granulosa cell tumor
    °ú¸³¸·¼¼Æ÷Á¾¾ç
  • islet cell
    µµ¼¼Æ÷
  • islet cell adenoma
    Ãéµµ¼¼Æ÷¼±Á¾
  • islet cell carcinoma
    µµ¼¼Æ÷¾ÏÁ¾
  • Langerhans' cell
    ¶û°Ô¸£Çѽº¼¼Æ÷
  • Langhans' glant cell
    ¶û±×Çѽº°Å¼¼Æ÷
  • large cell
    ´ë¼¼Æ÷
  • lymphoid cell
    ¸²ÇÁ¾ç¼¼Æ÷, ¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ±¸¾ç¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BET benign epithelial tumor; bleeding esophageal varix; Brunauer-Emmet-Teller [method]
BLEL benign lympho-epithelial lesion
CEOT calcifying epithelial odontogenic tumor
EECD endothelial-epithelial corneal dystrophy
EF ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HPAEC human pulmonary artery endothelial cell
PASMC Pulmonary artery smooth muscle cell
PNEC Pulmonary neuroendocrine cell
PASMC pulmonary arterial smooth muscle cell
BEC Biliary epithelial cells
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â, Æóµ¿¸ÆÆÇ Æó¼âÁõ
    ¿ì½É½Ç¿¡¼­ ±â½ÃÇÏ´Â Æó µ¿¸ÆÀÌ ¿ÏÀüÈ÷ ´ÜÀýµÇ¾î Ç÷·ù°¡ ³ª°¥ ¼ö ¾ø´Â »óŸ¦ ¸»ÇÑ´Ù. ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ÀÖÀ» ¼öµµ ÀÖ°í ¾øÀ» ¼öµµ Àִµ¥ ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ¾øÀ» °æ¿ì´Â ¿ì½É½Ç¿¡ Ç÷·ùÀÇ ºÎÇϰ¡ ³Ê¹« ¸¹ÀÌ °É·Á ž Á÷ÈĺÎÅÍ º¹ÀâÇÑ º´¸®¸¦ ³ªÅ¸³»¸ç ½ÉÇÑ Áõ¼¼¸¦ º¸ÀδÙ. À̶§´Â ¶ÇÇÑ ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß »ýÁ¸ÇÒ ¼ö ÀÖ´Ù. ½É½Ç Áß°Ý °á¼ÕÀÌ ¾ø´Â Æóµ¿¸ÆÀÇ Æó¼â´Â ¿ì½É½ÇÀÇ ºñ´ë´Â ¹°·Ð ¿ì½É½Ç¿¡¼­ °ü»ó µ¿¸ÆÀ¸·Î Ç÷·ù°¡ È帣´Â µî º¹ÀâÇÑ º´¸®°¡ ÀÖ´Ù. ±×¸®°í Æóµ¿¸Æ Æó¼â·Î ÀÎÇØ Æóµ¿¸ÆÀ¸·Î °¡´Â Ç÷·ù´Â ´ëµ¿¸Æ¿¡¼­ ±â½ÃÇØ¾ß Çϴµ¥ ÀÌ ¶ÇÇÑ ¸Å¿ì º¹ÀâÇÑ °æ·Î¸¦ ÅëÇØ ¿¬°áµÈ´Ù. ´Ü¼øÈ÷ Æóµ¿¸ÆÆÇ¸·¸¸ Æó¼âµÇ¾úÀ» °æ¿ì¿¡´Â µ¿¸Æ°ü °³Á¸ÁõÀ» ÅëÇØ Ç÷·ù°¡ À¯ÁöµÇ´Â °æ¿ì°¡ ¸¹Áö¸¸ ±×·¸Áö ¾Ê´Â °æ¿ì ´ëµ¿¸ÆÀÇ ¿©·¯ ±ºµ¥¿¡¼­ °¢°¢ µû·Îµû·Î Ç÷·ù°¡ ³ª¿Í ¼ö¼úÀ» ¸Å¿ì ¾î·Æ°Ô ¸¸µé ¼öµµ ÀÖ´Ù. ¼±Ãµ¼º û»öÁõÇü ½ÉÀ庴 Áß¿¡¼­µµ ¾î·Á¿î ¼ö¼ú ÁßÀÇ ÇϳªÀÌ´Ù. º´º¯ÀÌ º¹ÀâÇØ¼­ ÀÏ¹Ý ½ÉÀå ¼ö¼ú·Î ±³Á¤ÀÌ ºÒ°¡´ÉÇÒ ¶§´Â ½ÉÀå Æó µ¿½Ã À̽ÄÀ» ÇØÁÖ¾î¾ß ÇÑ´Ù.
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü ½û±â¾Ð
  • pulmonary collapse
    Æó ÇãÅ»
  • pulmonary cyanosis
    Æó¼º û»öÁõ
    Æó Ç÷¾×ÀÇ »ê¼Ò Æ÷È­ °áÇÌ¿¡ ÀÇÇÑ ÁßÃß¼º û»öÁõ.
  • pulmonary edema
    Æó ºÎÁ¾, Æó ¼öÁ¾
    ÆóÆ÷¿Í ¼¼±â°üÁö ³»¿¡ ¾×ü°¡ Âù »óÅÂ.
  • pulmonary emphysema
    Æó ±âÁ¾
    ÆóÆ÷°¡ ÇöÀúÇÏ°Ô È®ÀåÇÏ¿© ÆóÆ÷ ³»ÀÇ ÇԱⷮÀÌ Áõ°¡ÇÑ »óÅÂ. ¿©·¯ °¡Áö ¿øÀÎÀ¸·Î ÀϾÁö¸¸, °¡Àå º¸ÆíÀûÀ¸·Î º¼ ¼ö ÀÖ´Â °ÍÀº ³ëÀμº Æó±âÁ¾ÀÌ´Ù. ±× ¹Û¿¡ ±â°üÁö õ½Ä, ¸¸¼º ±â°üÁö¿° µîÀ¸·Î ÀϾ´Ù. Á÷¾÷º´À¸·Î¼­´Â ÃëÁ־DZâÀÇ ¿¬ÁÖÀÚ µî¿¡¼­µµ º¼ ¼ö ÀÖ´Ù. È£Èí °ï¶õ, ±âħ µîÀÇ Áõ¼¼¸¦ ³ªÅ¸³»¸ç, õ½Ä°ú ºñ½ÁÇÑ È£Èí °ï¶õµµ º¸ÀδÙ. ÁßÁõÀÎ °æ¿ì´Â ½ÉÀå¿¡ ºÎ´ãÀ» ÁÖ¾î Æó¼º ½ÉÀ¸·Î ÁøÇàÇÏ¿© ºÎÁ¾, Ä¡¾Æ³ëÁ¦°¡ ³ªÅ¸³­´Ù. ÈäºÎ X¼± »çÁø¿¡¼­´Â Æó¾ß°¡ ¹à°Ô ³ªÅ¸³ª°í, Ⱦ°Ý¸·ÀÌ Á¤»óº¸´Ù ³·Àº À§Ä¡¿¡ ÀÖ´Ù. Ä¡·á·Î¼­´Â ±â°üÁö È®ÀåÁ¦, ºÎ½Å ÇÇÁú È£¸£¸óÀÇ Åõ¿©°¡ À¯È¿ÇÏ´Ù. ÁßÁõÀÎ °æ¿ì´Â °­½ÉÁ¦¿Í ÀÌ´¢Á¦ÀÇ Åõ¿©³ª »ê¼Ò ÈíÀÔÀ» ÇÊ¿ä·Î ÇÑ´Ù.
  • pulmonary failure
    Æó ºÎÀü
  • pulmonary function
    Æó ±â´É
  • pulmonary hamartoma
    Æó °ú¿ÀÁ¾
  • pulmonary hemorrhage
    Æó ÃâÇ÷
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
  • pulmonary infarct
    Æó °æ»ö
  • pulmonary infection
    Æó °¨¿°
  • pulmonary insufficiency
    Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀü, Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀüÁõ, Æó ±â´É ºÎÀü
  • pulmonary lobule
    Æó ¼Ò¿±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
plexogenic pulmonary arteriopathy <syndrome> Sclerosis of the pulmonary arteries in chronic cor pulmonale; associated with severe cyanosis, it is a condition resembling polycythemia vera but resulting from primary pulmonary arteriosclerosis or primary pulmonary hypertension and characterised by plexiform lesions of arterioles.
Synonym: Ayerza's disease, cardiopathia nigra, plexogenic pulmonary arteriopathy.
(05 Mar 2000)
postcapillary pulmonary hypertension <radiology> Heart: LV failure, mitral stenosis, LA myxoma / thrombus, cor triatriatum, Pulmonary veins: congenital stenosis of pulmonary vein origin, mediastinal granulomata and neoplasms, idiopathic pulmonary veno-occlusive disease, anomalous pulmonary venous return
(12 Dec 1998)
posterior branch of right superior pulmonary vein <anatomy, vein> Drains posterior portion of superior lobe of right lung.
Synonym: ramus posterior venae pulmonalis dextrae superioris.
(05 Mar 2000)
precapillary pulmonary hypertension <radiology> Vascular: increased flow (left to right shunts), decreased flow (tetralogy of Fallot), primary pulmonary hypertension, thromboembolic disease, pulmonary arteritides, Pleuropulmonary: emphysema, diffuse lung disease, fibrothorax, chest deformity, hypoventilation, high-altitude pulmonary hypertension
(12 Dec 1998)
hantavirus pulmonary syndrome <syndrome> Acute respiratory illness in humans caused by the muerto canyon virus whose primary rodent reservoir is the deer mouse peromyscus maniculatus. First identified in the southwestern united states, this syndrome is characterised most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.
(12 Dec 1998)
primary pulmonary hypertension A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs. The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
primary pulmonary lobule The part of the airway consisting of a respiratory bronchiole and all of its branches.
Synonym: primary pulmonary lobule, respiratory lobule.
(05 Mar 2000)
sarcoidosis, pulmonary Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterised by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (cecil textbook of medicine, 19th ed, p431)
(12 Dec 1998)
high altitude pulmonary oedema <physiology> The abnormal deposition of fluid into the lungs that occurs with exposure to lower barometric pressure and low oxygen.
(12 Jan 1998)
secondary pulmonary lobule A pyramidal mass of lung tissue whose sides are bounded by the incomplete interlobular connective tissue septa and whose base, which is 1 to 2 cm in diameter, usually faces the pleural surface of the lung; lobule's that occupy a more central position in the lung are not well defined and are considered to consist of three to five pulmonary acini with proximate terminal bronchioles.
(05 Mar 2000)
pulmonary <anatomy, chest medicine> Pertaining to the lungs.
Origin: L. Pulmonarius
(06 Oct 1997)
pulmonary acariasis Infestation of the lungs of monkeys with the mite, Pneumonyssus simicola.
(05 Mar 2000)
pulmonary acinus The part of the airway consisting of a respiratory bronchiole and all of its branches.
Synonym: primary pulmonary lobule, respiratory lobule.
(05 Mar 2000)
pulmonary adenomatosis A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells; characterised by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain.
(05 Mar 2000)
pulmonary adenomatosis of sheep A chronic pulmonary disease of sheep of viral origin, caused by a member of Herpesviridae characterised by adenomatous proliferations in the alveoli and small bronchioles resembling neoplasia.
Synonym: jaagsiekte.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á